The Mechanism of Electroacupuncture for Depression on Basic Research: A Systematic Review

Han et al. · Chinese Medicine · 2021

📊Systematic Review🐭28 animal studiesHigh scientific impact

Evidence Level

STRONG
85/ 100
Quality
4/5
Sample
4/5
Replication
5/5
🎯

OBJECTIVE

To review the molecular mechanisms of electroacupuncture in the treatment of depression in animal models

👥

WHO

Rats and mice with depression induced by chronic stress

⏱️

DURATION

Studies from 1994 through December 2019

📍

POINTS

Mainly GV-20 (Baihui, 百会) and GV-29/EX-HN3 (Yintang, 印堂)

🔬 Study Design

28participants
randomization

Behavioral studies

n=11

Behavioral assessment after EA

Mechanistic studies

n=17

Molecular and biochemical analysis

⏱️ Duration: 25 years of scientific literature

📊 Results in numbers

2 Hz

Most commonly used EA frequency

0

Studies using 2 Hz EA

0

Studies using 100 Hz EA

28 of 1,163

Included studies

Percentage highlights

28 of 1,163
Included studies

📊 Outcome Comparison

Types of depression models used

CUMS (21 days)
15
WKY rats
3
Other models
10
💬 What does this mean for you?

This scientific review shows that electroacupuncture works to treat depression through multiple mechanisms in the brain, including regulation of neurotransmitters, reduction of inflammation, and protection of neurons. The most effective points are at the top of the head, and the 2 Hz frequency showed the best results.

📝

Article summary

Plain-language narrative summary

This scientific article represents an important contribution to our understanding of how electroacupuncture can help people who suffer from depression. The study offers a comprehensive view of the biological mechanisms involved in this treatment, drawing on experimental research with laboratory animals conducted over recent years.

Depression is considered one of the leading threats to global public health, affecting not only the nervous system but also potentially causing problems in multiple organs of the human body. Although traditional antidepressant medications are available, many have significant side effects, such as sexual dysfunction, gastrointestinal problems, drowsiness, and even suicidal ideation. This makes the search for safer and more effective therapeutic alternatives necessary.

Electroacupuncture is a technique that combines traditional Chinese acupuncture with controlled electrical stimulation. Unlike conventional acupuncture, in which only needles are inserted at specific points on the body, in electroacupuncture an electrical device is connected to the needles to deliver gentle, controlled electrical currents. Previous clinical studies have already shown that this technique can be as effective as conventional antidepressant medications but with fewer adverse effects and, in some cases, with a faster onset of action.

For this systematic analysis, the investigators followed rigorous scientific guidelines and searched multiple scientific databases, including English- and Chinese-language publications, from inception through December 2019. The aim was to identify all experimental animal studies that investigated how electroacupuncture works in the treatment of depression. After a careful screening of more than a thousand initially identified articles, 28 high-quality studies were selected for detailed analysis.

The analyzed studies primarily used well-established animal models to simulate human depression. The most common model was chronic unpredictable mild stress, in which animals are exposed to different types of stress over several weeks to develop behaviors similar to those seen in human depression. The most frequently used acupoints were two specific points on the animals' heads, equivalent to the Baihui and Yintang points in human clinical practice. Most studies used 2 Hz electrical stimulation, considered a low frequency, although some tested higher frequencies.

The results showed that electroacupuncture produces antidepressant effects through multiple simultaneous biological mechanisms, which explains its therapeutic efficacy. One of the main mechanisms identified involves regulation of the hypothalamic–pituitary–adrenal axis, a fundamental system in the body's stress response. When this system is hyperactive, as occurs in depression, there is excessive production of stress hormones. Electroacupuncture demonstrated the ability to normalize this system, reducing levels of hormones such as cortisol and adrenocorticotropic hormone.

Another important mechanism discovered relates to neuroplasticity — the brain's ability to form new connections and reorganize itself. Depression is associated with the loss of this plasticity, especially in the hippocampus, a brain region crucial for memory and emotional regulation. Electroacupuncture was shown to be able to restore synaptic plasticity in the hippocampus, promoting the formation of new neural connections and increasing the expression of a protein called BDNF (brain-derived neurotrophic factor), essential for neuronal survival and growth.

The study also identified that electroacupuncture acts on neurotransmitter systems, the chemical substances that allow communication between neurons. Specifically, it regulates the levels of serotonin, dopamine, and norepinephrine, neurotransmitters fundamental for mood and emotional well-being. In addition, the technique demonstrated anti-inflammatory capacity, reducing the production of proinflammatory cytokines in the brain, which are elevated in people with depression.

The clinical implications of these findings are significant for both patients and clinicians. For patients, the results suggest that electroacupuncture offers a valid and potentially safer therapeutic alternative to conventional antidepressants. The technique appears to work holistically, acting simultaneously on multiple biological systems that are dysregulated in depression. For clinicians, these data provide a solid scientific basis for considering electroacupuncture as an integral part of depression treatment, whether as monotherapy or in combination with other therapeutic approaches.

It is worth noting that some studies included in the analysis tested the combination of electroacupuncture with low doses of conventional antidepressants, observing synergistic effects that surpassed the results of either treatment alone. This suggests that integrating approaches may be particularly beneficial for some patients.

However, this study has some important limitations that should be considered. First, all the research was conducted in animal models, and although these are valuable for understanding biological mechanisms, direct translation to humans is not always guaranteed. In addition, most of the studies focused on specific mechanisms in isolation, not yet providing a fully integrated view of how all these processes interact simultaneously in the treatment of depression.

Another relevant limitation is that few studies directly compared the mechanisms of action of electroacupuncture with those of conventional antidepressants, which would be valuable for better understanding the differences and similarities between these therapeutic approaches. Future clinical studies in humans will be needed to confirm whether these mechanisms identified in animals translate effectively into therapeutic benefits for patients with depression.

In conclusion, this systematic review provides robust evidence that electroacupuncture exerts antidepressant effects through multiple complementary biological mechanisms, including hormonal regulation, improvement of neuroplasticity, modulation of neurotransmitters, and reduction of brain inflammation. These findings support the use of electroacupuncture as a promising therapeutic option for the treatment of depression, offering a potentially safer approach with fewer side effects than conventional pharmacologic treatments. However, more clinical research in humans is needed to fully validate these benefits and establish optimized treatment protocols for different types of depressed patients.

Strengths

  • 1Comprehensive review covering 25 years
  • 2Detailed analysis of molecular mechanisms
  • 3Identification of optimal points and parameters
  • 4Solid basis for clinical research
⚠️

Limitations

  • 1Animal studies only
  • 2Lack of standardization across studies
  • 3Complex mechanisms still not fully elucidated
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Depression responds only partially to the available antidepressants, and a considerable proportion of patients abandon pharmacologic treatment because of intolerance to adverse effects — sexual dysfunction, weight gain, sedation. This systematic review of 28 experimental studies, covering 25 years of basic research, offers the clinician a robust mechanistic map to ground the use of electroacupuncture in an integrative context. The convergence of findings points to simultaneous action on the hypothalamic–pituitary–adrenal axis, hippocampal neuroplasticity via BDNF, monoaminergic modulation, and neuroimmunomodulation — exactly the targets of the main available drugs. This positions electroacupuncture not as an empirical substitute but as a biologically plausible intervention in patients with mild to moderate depression, in those with documented pharmacologic intolerance, or in those seeking dose reduction with maintained efficacy. The 2 Hz frequency, used in 19 of the 28 studies and associated with the release of beta-endorphin and enkephalin, has a direct correlate in the clinical parameterization we already practice.

Notable Findings

The finding that most deserves attention is the consistency of the 2 Hz frequency as the dominant parameter — present in 19 of the 28 studies selected from an initial pool of 1,163 publications. This concentration is not trivial: low frequencies preferentially recruit endogenous opioid peptides and modulate the HPA axis differently from high frequencies, which has direct implications for protocol selection. The second relevant finding is the restoration of hippocampal neuroplasticity via BDNF upregulation — a mechanism that converges with that proposed for rapid-acting antidepressants such as ketamine, suggesting that electroacupuncture may share signaling pathways with cutting-edge interventions. Finally, studies that combined electroacupuncture with reduced doses of antidepressants demonstrated synergistic effects superior to either monotherapy, opening a clinically relevant therapeutic window for patients undergoing titration or supervised tapering.

From My Experience

In my practice in the pain and rehabilitation outpatient clinic, I have been following patients with depression comorbid with chronic musculoskeletal conditions — low-back pain, fibromyalgia, diffuse myofascial pain — and electroacupuncture at Baihui and Yintang, exactly the points predominant in this review, is frequently part of the protocol. I usually observe the first signs of improvement in mood and energy between the third and fifth sessions, which aligns with what the experimental literature suggests about the neuroplasticity window. For maintenance, I usually work with cycles of 10 to 12 sessions, followed by progressive spacing. I routinely combine this with supervised aerobic activity — which also raises BDNF — and maintain close coordination with the psychiatrist when pharmacotherapy is ongoing, especially in cases where we are seeking gradual dose reduction. I do not recommend electroacupuncture as monotherapy in severe depression with suicide risk or psychotic features. The profile that responds best, in my observation over the course of my career, is the patient with mild to moderate depression, clinically evident hypercortisolism, and prominent somatic complaints.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Chinese Medicine · 2021

DOI: 10.1186/s13020-020-00421-y

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.